NCT06979323View on ClinicalTrials.gov

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

PHASE3RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

February 11, 2028

Study Completion Date

February 11, 2028

Conditions

Asthma

Interventions

BIOLOGICAL

Depemokimab

Depemokimab will be administered.

Trial Locations (1)

33324

RECRUITING

GSK Investigational Site, Plantation

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY